Orpea: stock bubbling after H1 results
(CercleFinance.com) - The Orpea stock is up around 5% this morning after the group published its H1 sales numbers.
These reached 1,904.1 million euros, up +3.5%, with contributions made by acquisitions; particularly in Ireland, Latin America and France. Sales were down just 0.9% in organic terms.
The Central Europe region posted 5.4% over the period. The decline in Eastern Europe was exclusively due to the closure of the SRG clinics in Austria. Finally, the Iberian Peninsula and Latam region posted H1 revenue that matched its level in H1 2019, although Madrid and Barcelona were particularly impacted by the Covid-19 pandemic.
Orpea has also announced the acquisition of Clinipsy, an independent private group of psychiatric clinics. This company has nine establishments, with a total of 907 beds and places.
Copyright (c) 2020 CercleFinance.com. All rights reserved.
These reached 1,904.1 million euros, up +3.5%, with contributions made by acquisitions; particularly in Ireland, Latin America and France. Sales were down just 0.9% in organic terms.
The Central Europe region posted 5.4% over the period. The decline in Eastern Europe was exclusively due to the closure of the SRG clinics in Austria. Finally, the Iberian Peninsula and Latam region posted H1 revenue that matched its level in H1 2019, although Madrid and Barcelona were particularly impacted by the Covid-19 pandemic.
Orpea has also announced the acquisition of Clinipsy, an independent private group of psychiatric clinics. This company has nine establishments, with a total of 907 beds and places.
Copyright (c) 2020 CercleFinance.com. All rights reserved.